ScripBEIJING – Right before the Golden Week holiday weekend, the China FDA's drug review arm, the Center for Drug Evaluation (CDE), has released details of two sets of drugs – mainly for the hepatitis C vi
ScripAsia On The Move is a regular column highlighting industry personnel changes in Asia-Pacific. The previous issue covered China’s new deputy TCM Commissioner ( [A#28141201004] ). Send your sub
Pink SheetBEIJING - China’s largest contract research organization has joined the ranks of domestic innovative drug makers, establishing a unit billed as a gateway to China for global innovators. The Product De
ScripBEIJING - China’s largest contract research organization (CRO) has joined the ranks of domestic innovative drug makers, establishing a unit billed as a gateway to China for global innovators. The Prod